Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.
Salas S, Mercier C, Ciccolini J, Pourroy B, Fanciullino R, Tranchand B, Monjanel-Mouterde S, Baciuchka-Palmaro M, Dupuis C, Yang C, Balti M, Lacarelle B, Duffaud F, Durand A, Favre R.
Salas S, et al. Among authors: durand a.
Ther Drug Monit. 2006 Aug;28(4):532-9. doi: 10.1097/00007691-200608000-00008.
Ther Drug Monit. 2006.
PMID: 16885721
Clinical Trial.